IKELIA
Pierre Fabre Medicament
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87402706 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | G. Patrick SAGE |
| Attorney Name | G. Patrick SAGE |
| Attorney Docket Number | PF FTM 586 |
| Law Office Assigned | L40 |
| Employee Name | MARTIN, CHRISTINE C |
Timeline
| 2017-04-07 | Application Filed |
| 2017-10-17 | Published for Opposition |
| 2017-12-12 | Location: INTENT TO USE SECTION |
| 2018-07-16 | Abandon |
| 2018-07-16 | Status: Dead/Abandoned |
| 2018-07-16 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  PIERRE FABRE MEDICAMENT |
| Entity Statement | société par actions simplifiée (sas) |
| Address | 45 Place Abel Gance BOULOGNE BILLANCOU FR 92100 |
| Legal Entity Type | |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 3 |
| U.S. Codes: | 001,004,006,050,051,052 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0031 | Cosmetics; Dentifrices; Deodorant soap; Essential oils for personal use; Non-medicated hair care preparations; Perfumes; Skin soap; Toilet soaps |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-04-11 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-04-14 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-04-24 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2017-05-04 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-05-04 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-05-04 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-08-24 | 7 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2017-09-06 | 8 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-09-07 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-09-07 | 10 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-09-08 | 11 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-09-27 | 12 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-10-17 | 13 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-10-17 | 14 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-12-12 | 15 NOAM E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2018-07-16 | 16 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2018-07-16 | 17 MAB6 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 IKELIA 87402706 not registered Dead/Abandoned |
PIERRE FABRE MEDICAMENT 2017-04-07 |
 IKELIA 85012103 3953726 Dead/Cancelled |
PIERRE FABRE MEDICAMENT 2010-04-12 |
 IKELIA 76292879 2898543 Dead/Cancelled |
Pierre Fabre S.A. 2001-07-31 |
 IKELIA 74524093 1948056 Dead/Cancelled |
Pierre Fabre S.A. 1994-05-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 